Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Lucid Diagnostics (LUCD) News Today

→ How Biden has already won 2024 (From Porter & Company) (Ad)
Free LUCD Stock Alerts
$0.90
+0.02 (+2.26%)
(As of 05/17/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
May 18 at 5:02 AM | americanbankingnews.com
Lucid Diagnostics Inc. Forecasted to Earn FY2024 Earnings of ($1.06) Per Share (NASDAQ:LUCD)
May 17 at 6:06 AM | americanbankingnews.com
Lucid Diagnostics (NASDAQ:LUCD) Rating Reiterated by Cantor Fitzgerald
May 15, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Lucid Diagnostics Amid Positive Financial and Clinical Milestones
May 15, 2024 | americanbankingnews.com
Lucid Diagnostics' (LUCD) "Buy" Rating Reaffirmed at Needham & Company LLC
May 15, 2024 | finance.yahoo.com
Q1 2024 PAVmed Inc Earnings Call
May 14, 2024 | insidermonkey.com
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2024 Earnings Call Transcript
May 14, 2024 | finance.yahoo.com
Lucid Diagnostics Inc (LUCD) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
May 13, 2024 | prnewswire.com
PAVmed Provides Business Update and First Quarter 2024 Financial Results
May 13, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Jasper Therapeutics (JSPR) and Lucid Diagnostics (LUCD)
May 13, 2024 | investorplace.com
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024
May 13, 2024 | finance.yahoo.com
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
May 11, 2024 | americanbankingnews.com
Head to Head Analysis: Shockwave Medical (NASDAQ:SWAV) versus Lucid Diagnostics (NASDAQ:LUCD)
May 11, 2024 | americanbankingnews.com
Lucid Diagnostics (LUCD) to Release Quarterly Earnings on Monday
May 7, 2024 | prnewswire.com
Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors
May 6, 2024 | marketbeat.com
Lucid Diagnostics (LUCD) Scheduled to Post Earnings on Monday
Lucid Diagnostics (NASDAQ:LUCD) will be releasing earnings before the market opens on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=593600)
May 2, 2024 | prnewswire.com
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing
April 29, 2024 | prnewswire.com
Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month
April 26, 2024 | finance.yahoo.com
PAVmed Inc. (PAVM)
April 21, 2024 | nasdaq.com
Lucid Diagnostics Inc. Common Stock (LUCD)
April 19, 2024 | investorplace.com
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
April 15, 2024 | markets.businessinsider.com
Lucid Diagnostics: Strong Buy Rating with Significant Market Potential Despite Near-Term Losses
April 12, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Lucid Diagnostics Amidst Strong EsoGuard Testing Growth and Clear Reimbursement Path
April 10, 2024 | markets.businessinsider.com
Analysts Are Bullish on Top Healthcare Stocks: Lucid Diagnostics (LUCD), Werewolf Therapeutics (HOWL)
April 10, 2024 | investing.com
Lucid Diagnostics holds Buy rating, and stock target on company's performance
March 28, 2024 | seekingalpha.com
Lucid Diagnostics Inc. (LUCD) Q4 2023 Earnings Call Transcript
March 28, 2024 | markets.businessinsider.com
Buy Rating for Lucid Diagnostics: Solid Test Volumes and Strategic Growth Initiatives Propel Market Position
March 28, 2024 | finance.yahoo.com
PAVmed Inc. (NASDAQ:PAVM) Q4 2023 Earnings Call Transcript
March 28, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Lucid Diagnostics Amid Strong Financials and Strategic Growth Initiatives
March 27, 2024 | finanznachrichten.de
PAVmed Inc.: PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results
March 27, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Lucid Diagnostics Amidst Growing Test Volume and Strategic Positioning for Medicare Reimbursement
March 27, 2024 | finance.yahoo.com
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript
March 27, 2024 | finance.yahoo.com
Q4 2023 Lucid Diagnostics Inc Earnings Call
March 25, 2024 | investorplace.com
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023
March 25, 2024 | finance.yahoo.com
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results
March 21, 2024 | markets.businessinsider.com
Lucid Diagnostics Gets Positive Data From Clinical Validation Study Of EsoGuard Esophageal DNA Test
March 21, 2024 | prnewswire.com
Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population
March 20, 2024 | finance.yahoo.com
Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference
March 11, 2024 | marketbeat.com
Lucid Diagnostics (LUCD) to Release Earnings on Tuesday
Lucid Diagnostics (NASDAQ:LUCD) will be releasing earnings on Tuesday, March 12, Yahoo Finance reports.
February 21, 2024 | msn.com
Lucid Diagnostics target oesphageal cancer with early testing
February 16, 2024 | prnewswire.com
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program
February 16, 2024 | marketbeat.com
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Up 16.4% in January
Lucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 126,600 shares, an increase of 16.4% from the January 15th total of 108,800 shares. Currently, 1.8% of the company's shares are short sold. Based on an average daily volume of 44,700 shares, the short-interest ratio is presently 2.8 days.
February 15, 2024 | finance.yahoo.com
Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony
February 15, 2024 | prnewswire.com
Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony
February 8, 2024 | finanznachrichten.de
Lucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors
January 30, 2024 | marketbeat.com
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update
Lucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) saw a significant decline in short interest in January. As of January 15th, there was short interest totalling 108,800 shares, a decline of 8.5% from the December 31st total of 118,900 shares. Based on an average daily volume of 40,300 shares, the short-interest ratio is presently 2.7 days. Currently, 1.0% of the shares of the company are short sold.
December 30, 2023 | benzinga.com
Lucid Diagnostics Stock (NASDAQ:LUCD) Dividends: History, Yield and Dates
December 25, 2023 | finance.yahoo.com
The 3 Most Undervalued Penny Stocks to Buy in December
December 14, 2023 | za.investing.com
Needham reiterates Buy on Lucid Diagnostics following investor day
December 12, 2023 | morningstar.com
Lucid Diagnostics Inc LUCD
December 12, 2023 | finance.yahoo.com
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies
Get Lucid Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter.

CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)

Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.

Click on Adam's shiny forehead for more details.

LUCD Media Mentions By Week

LUCD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LUCD
News Sentiment
▼
-0.05

0.42
▲
Average
Medical
News Sentiment

LUCD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LUCD Articles
This Week
▼
17

1
▲
LUCD Articles
Average Week

Get Lucid Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:LUCD) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Shocking $16T Elon Musk Crypto Leak
Crypto 101 Media
Bill Gates is all about this tiny $2 stock
Timothy Sykes
The ONE AI Stock to own now. (It’s not Nvidia.)
Weiss Ratings
Urgent Nvidia Warning
Altimetry
Crypto Pioneer Says: “The last crypto bull market has begun.”
InvestorPlace
Buy this small stock before coming AI Tidal Wave
Chaikin Analytics
41 banks launch ‘crypto dollar’
Stansberry Research